Interference of low-molecular substances with the thioflavin-T fluorescence assay of amyloid fibrils

ABSTRACT Abnormal fibrillization of amyloidogenic peptides/proteins has been linked to various neurodegenerative diseases such as Alzheimer's and Parkinson's disease as well as with type‐II diabetes mellitus. The kinetics of protein fibrillization is commonly studied by using a fluorescent...

Full description

Saved in:
Bibliographic Details
Published inJournal of peptide science Vol. 18; no. 1; pp. 59 - 64
Main Authors Noormägi, Andra, Primar, Kateryna, Tõugu, Vello, Palumaa, Peep
Format Journal Article
LanguageEnglish
Published Chichester, UK John Wiley & Sons, Ltd 01.01.2012
Subjects
Online AccessGet full text

Cover

Loading…
Abstract ABSTRACT Abnormal fibrillization of amyloidogenic peptides/proteins has been linked to various neurodegenerative diseases such as Alzheimer's and Parkinson's disease as well as with type‐II diabetes mellitus. The kinetics of protein fibrillization is commonly studied by using a fluorescent dye Thioflavin T (ThT) that binds to protein fibrils and exerts increased fluorescence intensity in bound state. Recently, it has been demonstrated that several low‐molecular weight compounds like Basic Blue 41, Basic Blue 12, Azure C, and Tannic acid interfere with the fluorescence of ThT bound to Alzheimers' amyloid‐β fibrils and cause false positive results during the screening of fibrillization inhibitors. In the current study, we demonstrated that the same selected substances also decrease the fluorescence signal of ThT bound to insulin fibrils already at submicromolar or micromolar concentrations. Kinetic experiments show that unlike to true inhibitors, these compounds did neither decrease the fibrillization rate nor increase the lag‐period. Absence of soluble insulin in the end of the experiment confirmed that these compounds do not disaggregate the insulin fibrils and, thus, are not fibrillization inhibitors at concentrations studied. Our results show that interference with ThT test is a general phenomenon and more attention has to be paid to interpretation of kinetic results of protein fibrillization obtained by using fluorescent dyes. Copyright © 2011 European Peptide Society and John Wiley & Sons, Ltd. Basic Blue 41, Basic Blue 12, Azure C and Tannic acid decrease fluorescence intensity of ThT bound to insulin fibrils. In insulin fibrillization assay monitored by ThT fluorescence, these compounds show apparent inhibition of fibrillization. Unlike to true inhibitors, these compounds did not decreased the fibrillization rate or increased the lag‐period of insulin fibrillization.
AbstractList Abnormal fibrillization of amyloidogenic peptides/proteins has been linked to various neurodegenerative diseases such as Alzheimer's and Parkinson's disease as well as with type-II diabetes mellitus. The kinetics of protein fibrillization is commonly studied by using a fluorescent dye Thioflavin T (ThT) that binds to protein fibrils and exerts increased fluorescence intensity in bound state. Recently, it has been demonstrated that several low-molecular weight compounds like Basic Blue 41, Basic Blue 12, Azure C, and Tannic acid interfere with the fluorescence of ThT bound to Alzheimers' amyloid-β fibrils and cause false positive results during the screening of fibrillization inhibitors. In the current study, we demonstrated that the same selected substances also decrease the fluorescence signal of ThT bound to insulin fibrils already at submicromolar or micromolar concentrations. Kinetic experiments show that unlike to true inhibitors, these compounds did neither decrease the fibrillization rate nor increase the lag-period. Absence of soluble insulin in the end of the experiment confirmed that these compounds do not disaggregate the insulin fibrils and, thus, are not fibrillization inhibitors at concentrations studied. Our results show that interference with ThT test is a general phenomenon and more attention has to be paid to interpretation of kinetic results of protein fibrillization obtained by using fluorescent dyes.
ABSTRACT Abnormal fibrillization of amyloidogenic peptides/proteins has been linked to various neurodegenerative diseases such as Alzheimer's and Parkinson's disease as well as with type‐II diabetes mellitus. The kinetics of protein fibrillization is commonly studied by using a fluorescent dye Thioflavin T (ThT) that binds to protein fibrils and exerts increased fluorescence intensity in bound state. Recently, it has been demonstrated that several low‐molecular weight compounds like Basic Blue 41, Basic Blue 12, Azure C, and Tannic acid interfere with the fluorescence of ThT bound to Alzheimers' amyloid‐ β fibrils and cause false positive results during the screening of fibrillization inhibitors. In the current study, we demonstrated that the same selected substances also decrease the fluorescence signal of ThT bound to insulin fibrils already at submicromolar or micromolar concentrations. Kinetic experiments show that unlike to true inhibitors, these compounds did neither decrease the fibrillization rate nor increase the lag‐period. Absence of soluble insulin in the end of the experiment confirmed that these compounds do not disaggregate the insulin fibrils and, thus, are not fibrillization inhibitors at concentrations studied. Our results show that interference with ThT test is a general phenomenon and more attention has to be paid to interpretation of kinetic results of protein fibrillization obtained by using fluorescent dyes. Copyright © 2011 European Peptide Society and John Wiley & Sons, Ltd.
ABSTRACT Abnormal fibrillization of amyloidogenic peptides/proteins has been linked to various neurodegenerative diseases such as Alzheimer's and Parkinson's disease as well as with type‐II diabetes mellitus. The kinetics of protein fibrillization is commonly studied by using a fluorescent dye Thioflavin T (ThT) that binds to protein fibrils and exerts increased fluorescence intensity in bound state. Recently, it has been demonstrated that several low‐molecular weight compounds like Basic Blue 41, Basic Blue 12, Azure C, and Tannic acid interfere with the fluorescence of ThT bound to Alzheimers' amyloid‐β fibrils and cause false positive results during the screening of fibrillization inhibitors. In the current study, we demonstrated that the same selected substances also decrease the fluorescence signal of ThT bound to insulin fibrils already at submicromolar or micromolar concentrations. Kinetic experiments show that unlike to true inhibitors, these compounds did neither decrease the fibrillization rate nor increase the lag‐period. Absence of soluble insulin in the end of the experiment confirmed that these compounds do not disaggregate the insulin fibrils and, thus, are not fibrillization inhibitors at concentrations studied. Our results show that interference with ThT test is a general phenomenon and more attention has to be paid to interpretation of kinetic results of protein fibrillization obtained by using fluorescent dyes. Copyright © 2011 European Peptide Society and John Wiley & Sons, Ltd. Basic Blue 41, Basic Blue 12, Azure C and Tannic acid decrease fluorescence intensity of ThT bound to insulin fibrils. In insulin fibrillization assay monitored by ThT fluorescence, these compounds show apparent inhibition of fibrillization. Unlike to true inhibitors, these compounds did not decreased the fibrillization rate or increased the lag‐period of insulin fibrillization.
Author Primar, Kateryna
Palumaa, Peep
Noormägi, Andra
Tõugu, Vello
Author_xml – sequence: 1
  givenname: Andra
  surname: Noormägi
  fullname: Noormägi, Andra
  organization: Department of Gene Technology, Tallinn University of Technology, 12618, Akadeemia 15Tallinn, Estonia
– sequence: 2
  givenname: Kateryna
  surname: Primar
  fullname: Primar, Kateryna
  organization: Department of Gene Technology, Tallinn University of Technology, 12618, Akadeemia 15Tallinn, Estonia
– sequence: 3
  givenname: Vello
  surname: Tõugu
  fullname: Tõugu, Vello
  organization: Department of Gene Technology, Tallinn University of Technology, 12618, Akadeemia 15Tallinn, Estonia
– sequence: 4
  givenname: Peep
  surname: Palumaa
  fullname: Palumaa, Peep
  email: peepp@staff.ttu.ee, peepp@staff.ttu.ee
  organization: Department of Gene Technology, Tallinn University of Technology, 12618, Akadeemia 15Tallinn, Estonia
BackLink https://www.ncbi.nlm.nih.gov/pubmed/22083646$$D View this record in MEDLINE/PubMed
BookMark eNp1kF1v2yAUhtHUav2atF8w-W69cctHDPiyitquUtRWTabtDmF8UNmwScFuln8_vKS9mxACcR4enfOeoIM-9IDQZ4IvCMb0cp3MBZkR_gEdE1zXJWFSHEx3UZWUE3GETlL6hXGuVfwjOqIUS8Zn_Bi1d_0A0UKE3kARbOHDpuyCBzN6HYs0NmnQuZSKjRuei-EZ8nbBev3q-nJVWD-GCMn8-65T0ttJorutD64trGui8-kMHVrtE3zan6fo-831av6tXDzc3s2vFqVhleRlI2eGUcMpx2AIaY0UWrZUVsRiVkEFElqWFxf5iZFZ3eR5DFAB1hpCKTtFX3fedQwvI6RBdS635r3uIYxJ1YQJioWcyPMdaWJIKYJV6-g6HbeKYDVFqnKkaoo0o1_20rHpoH0H3zLMQLkDNs7D9r8i9bic74V73qUB_rzzOv5WXDBRqR_3t-pp8ZPVZCkUZn8BhIORmw
CitedBy_id crossref_primary_10_1021_ac503845f
crossref_primary_10_1002_chem_201704593
crossref_primary_10_1002_psc_3115
crossref_primary_10_3390_pathogens13060452
crossref_primary_10_1021_acs_analchem_6b04266
crossref_primary_10_3233_JAD_181001
crossref_primary_10_1016_j_neuint_2020_104806
crossref_primary_10_1371_journal_pone_0170266
crossref_primary_10_1089_dia_2014_0047
crossref_primary_10_1039_c3mb70201d
crossref_primary_10_1039_D0AN02260H
crossref_primary_10_1039_C8CC07164K
crossref_primary_10_1039_D1AY01126J
crossref_primary_10_1089_cbr_2012_1328
crossref_primary_10_3233_ADR_180066
crossref_primary_10_3233_JAD_150790
crossref_primary_10_1016_j_foodhyd_2020_106327
crossref_primary_10_1016_j_ijbiomac_2023_126331
crossref_primary_10_1208_s12248_016_0028_6
crossref_primary_10_1007_s00249_015_1019_8
crossref_primary_10_1016_j_cbpa_2017_06_008
crossref_primary_10_1038_ncomms9997
crossref_primary_10_3233_JAD_190758
crossref_primary_10_1016_j_ijbiomac_2024_133660
crossref_primary_10_1371_journal_pone_0121231
crossref_primary_10_1021_cn300076x
crossref_primary_10_1021_acschemneuro_5b00104
crossref_primary_10_7717_peerj_1271
crossref_primary_10_1039_c3an36798c
Cites_doi 10.1042/BJ20100627
10.1007/s11095-007-9516-9
10.1016/j.jsb.2004.08.002
10.1016/j.jsb.2007.06.004
10.1016/j.bcp.2009.04.034
10.1021/la063048k
10.1016/j.bbapap.2010.04.001
10.4161/isl.1.3.9609
10.1038/nature02261
10.1111/j.1471-4159.2009.06269.x
10.1021/ac101583q
10.1073/pnas.1002867107
10.1210/en.2010-0457
10.1038/nm0908-894
10.1038/nchembio.131
10.1038/nrd3050
10.1111/j.1742-4658.2009.07307.x
10.1021/jp070590o
ContentType Journal Article
Copyright Copyright © 2011 European Peptide Society and John Wiley & Sons, Ltd.
Copyright_xml – notice: Copyright © 2011 European Peptide Society and John Wiley & Sons, Ltd.
DBID BSCLL
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1002/psc.1416
DatabaseName Istex
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
CrossRef

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
EISSN 1099-1387
EndPage 64
ExternalDocumentID 10_1002_psc_1416
22083646
PSC1416
ark_67375_WNG_RLX391S7_0
Genre article
Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
.3N
.GA
.Y3
05W
0R~
10A
1L6
1OB
1OC
1ZS
31~
33P
3SF
3WU
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52S
52T
52U
52W
52X
53G
5GY
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A03
AAESR
AAEVG
AAHHS
AANLZ
AAONW
AASGY
AAXRX
AAZKR
ABCQN
ABCUV
ABEML
ABIJN
ABPVW
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFO
ACGFS
ACIWK
ACMXC
ACPOU
ACPRK
ACSCC
ACXBN
ACXQS
ADBBV
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFRAH
AFZJQ
AHBTC
AHMBA
AIAGR
AITYG
AIURR
AIWBW
AJBDE
AJXKR
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ASPBG
ATUGU
AUFTA
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BLYAC
BMNLL
BMXJE
BNHUX
BROTX
BRXPI
BSCLL
BY8
CS3
D-E
D-F
DCZOG
DPXWK
DR1
DR2
DRFUL
DRSTM
DU5
EBD
EBS
EJD
EMOBN
F00
F01
F04
F5P
FEDTE
G-S
G.N
GNP
GODZA
H.T
H.X
HF~
HGLYW
HHY
HHZ
HVGLF
HZ~
IX1
J0M
JPC
KQQ
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRSTM
MSFUL
MSSTM
MXFUL
MXSTM
N04
N05
N9A
NDZJH
NF~
O66
O9-
OIG
P2P
P2W
P2X
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
QRW
R.K
RBB
RIWAO
RJQFR
ROL
RWI
RX1
RYL
SAMSI
SUPJJ
SV3
UB1
V2E
V8K
W8V
W99
WBFHL
WBKPD
WIB
WIH
WIK
WJL
WOHZO
WQJ
WRC
WSB
WXSBR
WYISQ
XG1
XV2
Y6R
ZZTAW
~IA
~WT
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c3586-b84c32c6260ec11dc87a8d2851f035e5e8ed3d3d678513149b099ce27effc1223
IEDL.DBID DR2
ISSN 1075-2617
IngestDate Fri Aug 16 07:08:24 EDT 2024
Fri Aug 23 02:12:08 EDT 2024
Sat Sep 28 07:50:42 EDT 2024
Sat Aug 24 00:58:58 EDT 2024
Wed Oct 30 09:54:03 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License Copyright © 2011 European Peptide Society and John Wiley & Sons, Ltd.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3586-b84c32c6260ec11dc87a8d2851f035e5e8ed3d3d678513149b099ce27effc1223
Notes ark:/67375/WNG-RLX391S7-0
istex:63EF4ABBDFFF545594357562E94165BE89633AB8
ArticleID:PSC1416
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 22083646
PQID 913720782
PQPubID 23479
PageCount 6
ParticipantIDs proquest_miscellaneous_913720782
crossref_primary_10_1002_psc_1416
pubmed_primary_22083646
wiley_primary_10_1002_psc_1416_PSC1416
istex_primary_ark_67375_WNG_RLX391S7_0
PublicationCentury 2000
PublicationDate 2012-01
January 2012
2012-Jan
2012-01-00
20120101
PublicationDateYYYYMMDD 2012-01-01
PublicationDate_xml – month: 01
  year: 2012
  text: 2012-01
PublicationDecade 2010
PublicationPlace Chichester, UK
PublicationPlace_xml – name: Chichester, UK
– name: England
PublicationTitle Journal of peptide science
PublicationTitleAlternate J. Pept. Sci
PublicationYear 2012
Publisher John Wiley & Sons, Ltd
Publisher_xml – name: John Wiley & Sons, Ltd
References Krebs MR, Bromley EH, Donald AM. The binding of thioflavin-T to amyloid fibrils: localisation and implications. J. Struct. Biol. 2005; 149: 30-37.
Hawe A, Sutter M, Jiskoot W. Extrinsic fluorescent dyes as tools for protein characterization. Pharm. Res. 2008; 25: 1487-1499.
Levy-Sakin M, Shreberk M, Daniel Y, Gazit E. Targeting insulin amyloid assembly by small aromatic molecules: toward rational design of aggregation inhibitors. Islets 2009; 1: 210-215.
Zovo K, Helk E, Karafin A, Tõugu V, Palumaa P. Label-free high-throughput screening assay for inhibitors of Alzheimer's amyloid-β peptide aggregation based on MALDI MS. Anal. Chem. 2010; 82: 8558-8565.
Aguzzi A, O'Connor T. Protein aggregation diseases: pathogenicity and therapeutic perspectives. Nat. Rev. Drug Discov. 2010; 9: 237-248.
Chiti F, Dobson CM. Amyloid formation by globular proteins under native conditions. Nat. Chem. Biol. 2009; 5: 15-22.
Tougu V, Karafin A, Zovo K, Chung RS, Howells C, West AK, Palumaa P. Zn(II)- and Cu(II)-induced non-fibrillar aggregates of amyloid-beta (1-42) peptide are transformed to amyloid fibrils, both spontaneously and under the influence of metal chelators. J. Neurochem. 2009; 110: 1784-1795.
Gura T. Hope in Alzheimer's fight emerges from unexpected places. Nat. Med 2008; 14: 894.
Wolfe LS, Calabrese MF, Nath A, Blaho DV, Miranker AD, Xiong Y. Protein-induced photophysical changes to the amyloid indicator dye thioflavin T. Proc. Natl. Acad. Sci. U. S. A. 2010; 107: 16863-16868.
Stsiapura VI, Maskevich AA, Kuzmitsky VA, Turoverov KK, Kuznetsova IM. Computational study of thioflavin T torsional relaxation in the excited state. J. Phys. Chem. A 2007; 111: 4829-4835.
Bolder SG, Sagis LMC, Venema P, van der Linden E. Thioflavin T and birefringence assays to determine the conversion of proteins into fibrils. Langmuir 2007; 23: 4144-4147.
Lasagna-Reeves CA, Clos AL, Midoro-Hiriuti T, Goldblum RM, Jackson GR, Kayed R. Inhaled insulin forms toxic pulmonary amyloid aggregates. Endocrinology 2010; 151: 4717-4724.
Dobson CM. Protein folding and misfolding. Nature 2003; 426: 884-890.
Groenning M, Norrman M, Flink JM, van de Weert M, Bukrinsky JT, Schluckebier G, Frokjaer S. Binding mode of Thioflavin T in insulin amyloid fibrils. J. Struct. Biol. 2007; 159: 483-497.
Oz M, Lorke DE, Petroianu GA. Methylene blue and Alzheimer's disease. Biochem. Pharmacol. 2009; 78: 927-932.
Hudson SA, Ecroyd H, Kee TW, Carver JA. The thioflavin T fluorescence assay for amyloid fibril detection can be biased by the presence of exogenous compounds. FEBS J. 2009; 276: 5960-5972.
Noormagi A, Gavrilova J, Smirnova J, Tougu V, Palumaa P. Zn(II) ions co-secreted with insulin suppress inherent amyloidogenic properties of monomeric insulin. Biochem. J. 2010; 430: 511-518.
Biancalana M, Koide S. Molecular mechanism of Thioflavin-T binding to amyloid fibrils. Biochim. Biophys. Acta 2010; 1804: 1405-1412.
2009; 78
2007; 159
2003; 426
2010; 107
2007; 111
2005; 149
2009; 110
2008; 25
2008; 14
2010; 430
2009; 276
2010; 1804
2010; 151
2009; 5
2009; 1
2007; 23
2010; 9
2010; 82
e_1_2_6_10_1
e_1_2_6_9_1
e_1_2_6_8_1
e_1_2_6_19_1
e_1_2_6_5_1
e_1_2_6_4_1
e_1_2_6_7_1
e_1_2_6_6_1
e_1_2_6_13_1
e_1_2_6_14_1
e_1_2_6_3_1
e_1_2_6_11_1
e_1_2_6_2_1
e_1_2_6_12_1
e_1_2_6_17_1
e_1_2_6_18_1
e_1_2_6_15_1
e_1_2_6_16_1
References_xml – volume: 149
  start-page: 30
  year: 2005
  end-page: 37
  article-title: The binding of thioflavin‐T to amyloid fibrils: localisation and implications
  publication-title: J. Struct. Biol.
– volume: 1804
  start-page: 1405
  year: 2010
  end-page: 1412
  article-title: Molecular mechanism of Thioflavin‐T binding to amyloid fibrils
  publication-title: Biochim. Biophys. Acta
– volume: 111
  start-page: 4829
  year: 2007
  end-page: 4835
  article-title: Computational study of thioflavin T torsional relaxation in the excited state
  publication-title: J. Phys. Chem. A
– volume: 9
  start-page: 237
  year: 2010
  end-page: 248
  article-title: Protein aggregation diseases: pathogenicity and therapeutic perspectives
  publication-title: Nat. Rev. Drug Discov.
– volume: 430
  start-page: 511
  year: 2010
  end-page: 518
  article-title: Zn(II) ions co‐secreted with insulin suppress inherent amyloidogenic properties of monomeric insulin
  publication-title: Biochem. J.
– volume: 14
  start-page: 894
  year: 2008
  article-title: Hope in Alzheimer's fight emerges from unexpected places
  publication-title: Nat. Med
– volume: 1
  start-page: 210
  year: 2009
  end-page: 215
  article-title: Targeting insulin amyloid assembly by small aromatic molecules: toward rational design of aggregation inhibitors
  publication-title: Islets
– volume: 151
  start-page: 4717
  year: 2010
  end-page: 4724
  article-title: Inhaled insulin forms toxic pulmonary amyloid aggregates
  publication-title: Endocrinology
– volume: 23
  start-page: 4144
  year: 2007
  end-page: 4147
  article-title: Thioflavin T and birefringence assays to determine the conversion of proteins into fibrils
  publication-title: Langmuir
– volume: 5
  start-page: 15
  year: 2009
  end-page: 22
  article-title: Amyloid formation by globular proteins under native conditions
  publication-title: Nat. Chem. Biol.
– volume: 25
  start-page: 1487
  year: 2008
  end-page: 1499
  article-title: Extrinsic fluorescent dyes as tools for protein characterization
  publication-title: Pharm. Res.
– volume: 82
  start-page: 8558
  year: 2010
  end-page: 8565
  article-title: Label‐free high‐throughput screening assay for inhibitors of Alzheimer's amyloid‐β peptide aggregation based on MALDI MS
  publication-title: Anal. Chem.
– volume: 159
  start-page: 483
  year: 2007
  end-page: 497
  article-title: Binding mode of Thioflavin T in insulin amyloid fibrils
  publication-title: J. Struct. Biol.
– volume: 426
  start-page: 884
  year: 2003
  end-page: 890
  article-title: Protein folding and misfolding
  publication-title: Nature
– volume: 78
  start-page: 927
  year: 2009
  end-page: 932
  article-title: Methylene blue and Alzheimer's disease
  publication-title: Biochem. Pharmacol.
– volume: 107
  start-page: 16863
  year: 2010
  end-page: 16868
  article-title: Protein‐induced photophysical changes to the amyloid indicator dye thioflavin T
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
– volume: 276
  start-page: 5960
  year: 2009
  end-page: 5972
  article-title: The thioflavin T fluorescence assay for amyloid fibril detection can be biased by the presence of exogenous compounds
  publication-title: FEBS J.
– volume: 110
  start-page: 1784
  year: 2009
  end-page: 1795
  article-title: Zn(II)‐ and Cu(II)‐induced non‐fibrillar aggregates of amyloid‐beta (1–42) peptide are transformed to amyloid fibrils, both spontaneously and under the influence of metal chelators
  publication-title: J. Neurochem.
– ident: e_1_2_6_6_1
  doi: 10.1042/BJ20100627
– ident: e_1_2_6_9_1
  doi: 10.1007/s11095-007-9516-9
– ident: e_1_2_6_8_1
  doi: 10.1016/j.jsb.2004.08.002
– ident: e_1_2_6_17_1
  doi: 10.1016/j.jsb.2007.06.004
– ident: e_1_2_6_18_1
  doi: 10.1016/j.bcp.2009.04.034
– ident: e_1_2_6_12_1
  doi: 10.1021/la063048k
– ident: e_1_2_6_10_1
  doi: 10.1016/j.bbapap.2010.04.001
– ident: e_1_2_6_15_1
  doi: 10.4161/isl.1.3.9609
– ident: e_1_2_6_4_1
  doi: 10.1038/nature02261
– ident: e_1_2_6_7_1
  doi: 10.1111/j.1471-4159.2009.06269.x
– ident: e_1_2_6_13_1
  doi: 10.1021/ac101583q
– ident: e_1_2_6_5_1
  doi: 10.1073/pnas.1002867107
– ident: e_1_2_6_16_1
  doi: 10.1210/en.2010-0457
– ident: e_1_2_6_19_1
  doi: 10.1038/nm0908-894
– ident: e_1_2_6_2_1
  doi: 10.1038/nchembio.131
– ident: e_1_2_6_3_1
  doi: 10.1038/nrd3050
– ident: e_1_2_6_14_1
  doi: 10.1111/j.1742-4658.2009.07307.x
– ident: e_1_2_6_11_1
  doi: 10.1021/jp070590o
SSID ssj0009956
Score 2.143875
Snippet ABSTRACT Abnormal fibrillization of amyloidogenic peptides/proteins has been linked to various neurodegenerative diseases such as Alzheimer's and Parkinson's...
Abnormal fibrillization of amyloidogenic peptides/proteins has been linked to various neurodegenerative diseases such as Alzheimer's and Parkinson's disease as...
SourceID proquest
crossref
pubmed
wiley
istex
SourceType Aggregation Database
Index Database
Publisher
StartPage 59
SubjectTerms aggregation
amyloid
Amyloid - analysis
Amyloid - metabolism
Amyloid beta-Peptides - analysis
Amyloid beta-Peptides - metabolism
Azure Stains - adverse effects
Azure Stains - metabolism
Biological Assay
Diabetes Mellitus, Type 2 - diagnosis
Diabetes Mellitus, Type 2 - metabolism
False Positive Reactions
fibrillization
fluorescence
Fluorescent Dyes - analysis
Fluorescent Dyes - metabolism
Humans
insulin
Insulin - analysis
Insulin - metabolism
Kinetics
Neurodegenerative Diseases - diagnosis
Neurodegenerative Diseases - metabolism
Protein Structure, Secondary
Spectrometry, Fluorescence
Tannins - adverse effects
Tannins - metabolism
Thiazoles - analysis
Thiazoles - antagonists & inhibitors
Thiazoles - metabolism
Title Interference of low-molecular substances with the thioflavin-T fluorescence assay of amyloid fibrils
URI https://api.istex.fr/ark:/67375/WNG-RLX391S7-0/fulltext.pdf
https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fpsc.1416
https://www.ncbi.nlm.nih.gov/pubmed/22083646
https://search.proquest.com/docview/913720782
Volume 18
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB5VVGp7KY9SWFqQkareAmvn4eRYbXkIAap4qCtxsBzHFitCgja7bempP6G_sb-kM3ksoioSQlGUizNxPGP7sz3zDcCHLMoytBTn0SGah_g_8VJupGeTNDIusVLGFJx8dBztnwcHw3DYelVSLEzDDzHbcKOeUY_X1MF1Wm3fkYbeVAa7OSe2be5L8ub6fHLHHEUBm427ITlxcdnxzvbFdvfivZnoOTXqj__BzPuotZ52dufhoqtw421ytTWdpFvm5z9cjk_7owV43aJR9qkxn0V4ZosleDnoksAtwYuj9uz9DVzWm4dteCArHcvL739-_b7u8uuyCsegCRlRxWh3lyG0xHtUulx_GxVY9Iy5fFqOawIpFIGwXd-SIH19m5ejjDkKP8irZTjf3Tkb7HttngbP-GEceWkcGF8YWhpZw3lmYqnjTCCWc30_tKGNbebjhfNiyH1ckqWoHmOFtM4ZjvjkLcwVZWFXgQU69aVDaRHCHB0YHWXC9RM0tCgS2ogebHY6UzcNHYdqiJeFwuZT1Hw9-Fgrc1ZAj6_IfU2G6uvxnjo5HPoJP5Wq3wPWaVths9JJiS5sOa1Uwil5D4KnHqw0VjATJgTxeQf0lVqXD1ZDfTkd0HPtsQXfwStEY6LZ33kPc5Px1K4j4pmkG7Vt_wUsHP8l
link.rule.ids 315,783,787,1378,27938,27939,46308,46732
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1fb9MwED-NTWJ74c-AUf4aCfGWrXESOxFPqDAKtBXaOtEHJMtxbFEtS6amBbanfQQ-I5-Eu6TpNAQSQlGUF8dxfGf75_Pd7wCeZyLLUFOcR4doHuL_xEt9Iz2bpMK4xEoZU3DycCT6R-H7STRZg5dtLEzDD7EyuNHIqOdrGuBkkN67ZA09rQyOc19cgw0c7QGlL3h9cMkdRSGbjcMhuXH5smWe7fK99s0ra9EGdev3PwHNq7i1Xnj2b8LntsmNv8nx7mKe7prz39gc__OfbsGNJSBlrxoNug1rttiGzV6bB24brg-Xx-934EttP1xGCLLSsbz89vPix0mbYpdVOA3NSY8qRgZehugS72npcv11WmDRMXP5opzVHFJYBSJ3fUYV6ZOzvJxmzFEEQl7dhaP9N-Ne31umavBMEMXCS-PQBNzQ7sga389MLHWccYRzrhtENrKxzQK8cGmM_AB3ZSnKx1gurXPGR4hyD9aLsrD3gYU6DaTD2gQiHR0aLTLuugnqmhBcG96BZ63Q1GnDyKEa7mWusPsUdV8HXtTSXBXQs2PyYJOR-jR6qw4GkyDxD6XqdoC14lbYrXRYogtbLiqV-JS_B_FTB3YaNVhVxjlReof0lVqYf22G-njYo-eDfy34FDb74-FADd6NPjyELQRnvDH3PIL1-WxhHyMAmqdPakX_BQZDA04
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB5BKxUuPMpreRoJcUsbO4mTHNGWpUC7qvoQK3GwHMcWq6bJarMLlBM_gd_IL2Emj62KQEIoinJxJo5nbH-2Z74BeJHLPEdLcR4donmI_1Mv4yb2bJpJ41IbxwkFJ--P5e5J-G4STTqvSoqFafkhVhtu1DOa8Zo6-Cx32xekobPaYDfn8iqshzLwyZ1r5_CCOooiNlt_Q_Li4nFPPOuL7f7NS1PROrXq1z_hzMuwtZl3RjfhY1_j1t3kdGu5yLbMt9_IHP_vl27BjQ6Oslet_dyGK7bchGvDPgvcJmzsd4fvd-BTs3vYxQeyyrGi-vLz-4-zPsEuq3EQWpAV1Yy2dxliS7ynlSv052mJRY-ZK5bVvGGQQhGI2_U5CdJn50U1zZmj-IOivgsno9fHw12vS9TgmSBKpJcloQmEobWRNZznJol1kgsEc84PIhvZxOYBXjgxRjzANVmG6jFWxNY5wxGg3IO1sirtA2ChzoLYoTSJOEeHRstcOD9FS5NSaCMG8LzXmZq1fByqZV4WCptPUfMN4GWjzFUBPT8l_7U4Uh_Gb9Th3iRI-VGs_AGwXtsKm5WOSnRpq2WtUk7ZexA9DeB-awUrYUIQoXdIX2l0-ddqqIOjIT0f_mvBZ7BxsDNSe2_H7x_BdURmot3reQxri_nSPkH0s8ieNmb-CwinAf0
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Interference+of+low%E2%80%90molecular+substances+with+the+thioflavin%E2%80%90T+fluorescence+assay+of+amyloid+fibrils&rft.jtitle=Journal+of+peptide+science&rft.au=Noorm%C3%A4gi%2C+Andra&rft.au=Primar%2C+Kateryna&rft.au=T%C3%B5ugu%2C+Vello&rft.au=Palumaa%2C+Peep&rft.date=2012-01-01&rft.issn=1075-2617&rft.eissn=1099-1387&rft.volume=18&rft.issue=1&rft.spage=59&rft.epage=64&rft_id=info:doi/10.1002%2Fpsc.1416&rft.externalDBID=n%2Fa&rft.externalDocID=10_1002_psc_1416
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1075-2617&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1075-2617&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1075-2617&client=summon